Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study-Reference-Cited by-同舟云学术

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

Published:2015-10 Issue:10003 Volume:386 Page:1537-1545
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Roth David,Nelson David R,Bruchfeld Annette,Liapakis AnnMarie,Silva Marcelo,Monsour Howard,Martin Paul,Pol Stanislas,Londoño Maria-Carlota,Hassanein Tarek,Zamor Philippe J,Zuckerman Eli,Wan Shuyan,Jackson Beth,Nguyen Bach-Yen,Robertson Michael,Barr Eliav,Wahl Janice,Greaves Wayne

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?;Fabrizi;J Viral Hepat,2012

2. HCV infection and the incidence of CKD;Butt;Am J Kidney Dis,2011

3. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease;Tsui;Arch Intern Med,2007

4. Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis;Noureddine;Am J Nephrol,2010

5. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation;Pereira;Transplantation,1995

Cited by 610 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing hepatitis C management in ESRD: Evaluating efficacy and safety of alternative antiviral regimens;Therapeutic Apheresis and Dialysis;2024-09-14

2. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir in Treating HCV Genotypes 1 and 4 in Patients with Advanced Chronic Kidney Disease;Journal of Pharmacy and Bioallied Sciences;2024-07

3. Antivirales de acción directa contra la hepatitis C: revisión narrativa;Hepatología;2024-05-02

4. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

5. The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study;Clinics and Research in Hepatology and Gastroenterology;2023-12